Alnylam Pharmaceuticals, Inc.
NASDAQ: ALNY
$128.31
-$1.00 (-0.8%)
Closing price May 18, 2022
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial and FDA updates in April.
4 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and other research calls from Wednesday include Accenture, American Expresss, Cognizant Technology Solutions, FireEye, Mastercard, PayPal, Verizon and Visa.
4 years ago
Last Updated: 2 years ago
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
4 years ago
Last Updated: 2 years ago
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
4 years ago
Last Updated: 2 years ago
With 2017 nearing an end, it is important to consider just what has happened. 24/7 Wall St. has screened 50 stocks that have risen 100% or more (some far more) in 2017.
4 years ago
Last Updated: 8 months ago
The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under Armour.
4 years ago
Last Updated: 2 years ago
Source: courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull...
4 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and other research calls from Wednesday include Axovant, Carnival, Micron Technology, Nike, SunPower, Vivint Solar and Walgreens.
4 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and other research calls from Thursday include AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron Technology, Albermarle and Alnylam Pharmaceuticals.
4 years ago
Last Updated: 2 years ago
Alnylam Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage trial in patients with hereditary ATTR amyloidosis with polyneuropathy.
4 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and other research calls from Tuesday include Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess and Western Digital.
4 years ago
Last Updated: 2 years ago
Jefferies has picked out a few companies in the biotech industry that stand to win big over the coming year.
4 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and other research calls from Friday include Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty and Yum China.
4 years ago
Last Updated: 2 years ago
The the top analyst upgrades, downgrades and other research calls from Tuesday include AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy and Yum Brands.
5 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and initiations seen from Monday include Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald's and Snap.
5 years ago
Last Updated: 2 years ago